Highlights: Completed the sale of the RAL business with net proceeds of US $607.7 million in cash.Leverage Ratio1,2 improved to 1.4 at December 31, 2024 from 3.3 at December 31, 2023.Net loss from ...
MENLO PARK, Calif., Feb. 20, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today reported business and financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback